Conavi Medical Corp.
CNVI.V
TSX
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 27.29% | 2.46% | 69.23% | -23.87% | -77.08% |
| Total Depreciation and Amortization | 2.61% | -2.47% | -16.03% | -1.91% | -16.69% |
| Total Amortization of Deferred Charges | 4.00% | -3.10% | -23.67% | -- | -- |
| Total Other Non-Cash Items | 43.43% | 2.46% | -115.22% | 139.27% | 113.58% |
| Change in Net Operating Assets | -1,501.97% | -2.46% | -80.85% | -57.18% | 4,945.65% |
| Cash from Operations | -30.13% | 2.46% | -34.94% | 18.13% | -5.54% |
| Capital Expenditure | 77.95% | 2.50% | 82.85% | -47.78% | 31.15% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -100.00% | -2.46% | 3,963.77% | -39.11% | 65.17% |
| Cash from Investing | -100.34% | -2.46% | 969.54% | -45.47% | 44.13% |
| Total Debt Issued | -- | -- | -- | -24.31% | -- |
| Total Debt Repaid | -6.60% | 0.00% | -136.18% | 23.77% | 18.01% |
| Issuance of Common Stock | 140.03% | 0.00% | -- | -- | -100.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 302.21% | -2.46% | 34.68% | -24.09% | 1,726.82% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 3,443.64% | -2.47% | 122.31% | -12.23% | 79.49% |